Liver transplantation for hepatocellular carcinoma.
暂无分享,去创建一个
[1] John Wong,et al. Natural History of Untreated Nonsurgical Hepatocellular Carcinoma , 2005, The American Journal of Gastroenterology.
[2] J. Belghiti,et al. Surgical treatment of hepatocellular carcinoma. , 2005, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[3] Günter Tusch,et al. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients , 1991, World Journal of Surgery.
[4] J. Hiatt,et al. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[5] L. Mariani,et al. Radiofrequency Ablation of Small Hepatocellular Carcinoma in Cirrhotic Patients Awaiting Liver Transplantation: A Prospective Study , 2004, Annals of surgery.
[6] J. Bruix,et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: An indication for salvage liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[7] S. Thorgeirsson,et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling , 2004, Hepatology.
[8] J. Weissman,et al. Disparity in use of orthotopic liver transplantation among blacks and whites , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[9] E. Furth,et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[10] J. Roberts,et al. Applying expanded criteria to liver transplantation for hepatocellular carcinoma: Too much too soon, or is now the time? , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[11] S. Hain,et al. Recent Advances in Imaging Hepatocellular Carcinoma: Diagnosis, Staging and Response Assessment Functional Imaging , 2004, Cancer journal.
[12] S. Fan,et al. The role and limitation of living donor liver transplantation for hepatocellular carcinoma , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[13] G. Gores,et al. Drop‐out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[14] M. Fiorentino,et al. Predictive Value of Biological Markers for Hepatocellular Carcinoma Patients Treated with Orthotopic Liver Transplantation , 2004, Clinical Cancer Research.
[15] M. Rugge,et al. Liver Transplantation for the Treatment of Moderately or Well-Differentiated Hepatocellular Carcinoma , 2004, Annals of surgery.
[16] G. Everson,et al. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] D. D’amico,et al. Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing. , 2003, Transplantation proceedings.
[18] E. Abdalla,et al. Resection Prior to Liver Transplantation for Hepatocellular Carcinoma , 2003, Annals of surgery.
[19] J. Geschwind,et al. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] J. Emond,et al. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[21] W. Jarnagin,et al. Resection of Hepatocellular Carcinoma in Patients Otherwise Eligible for Transplantation , 2003, Annals of surgery.
[22] Usefulness of chemotherapy as prophylaxis of tumor recurrence after liver transplantation in advanced hepatocellular carcinomas. , 2003, Transplantation proceedings.
[23] S. Finkelstein,et al. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence‐free survival , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[24] R. Gish,et al. A model to predict severe HCV‐related disease following liver transplantation , 2003, Hepatology.
[25] P. Waldenberger,et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[26] S. Finkelstein,et al. Microdissection‐based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma , 2003, Hepatology.
[27] X. Wang,et al. Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning , 2003, Nature Medicine.
[28] N. Iizuka,et al. MECHANISMS OF DISEASE Mechanisms of disease , 2022 .
[29] S. Fan,et al. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis , 2003, The Journal of pathology.
[30] J. Bruix,et al. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival , 2003, Hepatology.
[31] J. Roberts,et al. 3 The impact of expansion of conventional tumor criteria and pre-operative loco-regional treatments on survival following liver transplantation for hepatocellular carcinoma: results from two centers , 2003 .
[32] R. Wiesner,et al. Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.
[33] Kenneth H Buetow,et al. A phylogenetic analysis identifies heterogeneity among hepatocellular carcinomas. , 2002, Hepatology.
[34] J. Marrero,et al. NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States , 2002, Hepatology.
[35] H. El‐Serag. Hepatocellular carcinoma and hepatitis C in the United States , 2002, Hepatology.
[36] T. Davern,et al. Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention‐to‐treat principle and dropout from the waiting list , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[37] M. Roncalli,et al. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma , 2002, Hepatology.
[38] Mauro Salizzoni,et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. , 2002, Gastroenterology.
[39] G. Everson,et al. Adult-to-adult transplantation of the right hepatic lobe from a living donor. , 2002, The New England journal of medicine.
[40] Charles M. Miller,et al. Long-Term Results With Multimodal Adjuvant Therapy and Liver Transplantation for the Treatment of Hepatocellular Carcinomas Larger Than 5 Centimeters , 2002, Annals of surgery.
[41] Charles M. Miller,et al. Hepatocellular carcinoma: A prime indication for living donor liver transplantation , 2002, Journal of Gastrointestinal Surgery.
[42] J. Fung,et al. Ethical considerations and rationale of adult‐to‐adult living donor liver transplantation , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[43] L Pagliaro,et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.
[44] B. Sangro,et al. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[45] A. Venook,et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.
[46] J. Bruix,et al. Living donor liver transplantation for early hepatocellular carcinoma: A life‐expectancy and cost‐effectiveness perspective , 2001, Hepatology.
[47] P Neuhaus,et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis , 2001, Hepatology.
[48] H B el-Serag. Epidemiology of hepatocellular carcinoma. , 2001, Clinics in liver disease.
[49] J. J. Robinson,et al. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture , 2001, Nature Genetics.
[50] S. Hirohashi,et al. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis—A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma , 2000, Hepatology.
[51] G. Korbutt,et al. Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Is a Death Receptor for Granzyme B during Cytotoxic T Cell–Induced Apoptosis , 2000, Cell.
[52] R. Freeman,et al. Liver transplant waiting time does not correlate with waiting list mortality: Implications for liver allocation policy , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[53] Chi-Hung Lin,et al. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. , 2000, Gastroenterology.
[54] J. Sheu,et al. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13–p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region , 2000, Genes, chromosomes & cancer.
[55] M. Laeeq Khan,et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. , 2000, Journal of hepatology.
[56] P. Majno,et al. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome‐oriented decision analysis , 2000, Hepatology.
[57] P. Kamath,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.
[58] J. Ahn,et al. Hepatic arterial complications in liver transplant recipients treated with pretransplantation chemoembolization for hepatocellular carcinoma. , 2000, Radiology.
[59] S. Iwatsuki,et al. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? , 2000, Cancer.
[60] J. Bruix,et al. Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.
[61] T. Arima,et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection , 1999, Cancer.
[62] T. Starzl,et al. Should hepatomas be treated with hepatic resection or transplantation? , 1999, Cancer.
[63] R. D. de Man,et al. Subcutaneous seeding of hepatocellular carcinoma after percutaneous needle biopsy , 1999, Gut.
[64] G. Gores,et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[65] L Solbiati,et al. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. , 1999, Radiology.
[66] S. Caldwell,et al. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.
[67] J. Bruix,et al. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials , 1999, Hepatology.
[68] H. Bismuth,et al. Liver Transplantation for Hepatocellular Carcinoma , 1999, Seminars in liver disease.
[69] C. Herfarth,et al. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. , 1998, Annals of surgery.
[70] H. Bismuth,et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. , 1997, Annals of surgery.
[71] S. Finkelstein,et al. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[72] E. P. Popechitelev,et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study , 1997, Hepatology.
[73] V. Mazzaferro,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[74] C. Bartolozzi,et al. Small Hepatocellular Carcinoma , 1996, Acta radiologica.
[75] M. Washington,et al. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity , 1995, Nature Genetics.
[76] J. Figueras,et al. Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma? , 1995, Transplantation proceedings.
[77] K. Olthoff,et al. Adjuvant Chemotherapy Improves Survival After Liver Transplantation for Hepatocellular Carcinoma , 1995, Annals of surgery.
[78] T. Hanafusa,et al. Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma , 1995, Journal of gastroenterology and hepatology.
[79] H. Sakai,et al. Subcutaneous seeding of hepatocellular carcinoma following fine-needle aspiration biopsy. , 1993, Journal of clinical gastroenterology.
[80] H. Bismuth,et al. Liver Resection Versus Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients , 1993, Annals of surgery.
[81] A. Venook. Liver transplantation for hepatocellular carcinoma , 1993, Hepatology.
[82] T. Starzl,et al. Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. , 1993, Transplantation proceedings.
[83] R. Pichlmayer. Liver transplantation in primary hepatocellular carcinoma. , 1993, Journal of hepatology.
[84] G. Gores,et al. Progress in orthotopic liver transplantation for hepatocellular carcinoma. , 1993, Gastroenterology.
[85] D. V. van Thiel,et al. Hepatic resection versus transplantation for hepatocellular carcinoma. , 1991, Annals of surgery.
[86] B J Ott,et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. , 1990, Gastroenterology.
[87] K. Olthoff,et al. Is liver transplantation justified for the treatment of hepatic malignancies? , 1990, Archives of surgery.
[88] K. Buetow,et al. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[89] T. Starzl,et al. Liver transplantation for malignant tumors. , 1988, Gastroenterology clinics of North America.
[90] T. Starzl,et al. Role of Liver Transplantation in Cancer Therapy , 1985, Annals of surgery.
[91] W. Chapman,et al. Orthotopic liver transplantation , 1980 .